|
"huang c f"的相關文件
顯示項目 91-100 / 886 (共89頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2022 |
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals
|
Chen, Y.-C.;Chang, T.-S.;Chen, Chen C.-H.;Cheng, P.-N.;Lo, C.-C.;Mo, L.-R.;Chen, Chen C.-T.;Huang, C.-F.;Kuo, H.-T.;Huang, Y.-H.;Tai, C.-M.;Peng, C.-Y.;Bair, M.-J.;Yeh, M.-L.;Lin, C.-L.;Lin, C.-Y.;Lee, P.-L.;Chong, L.-W.;Hung, C.-H.;Huang, J.-F.;Yang, C.-C.;Hu, J.-T.;Lin, C.-W.;Wang, C.-C.;Su, W.-W.;Hsieh, T.-Y.;Lin, C.-L.;Tsai, W.-L.;Lee, T.-H.;Chen, G.-Y.;Wang, S.-J.;Chang, Chang C.-C.;Yang, S.-S.;Wu, Wu W.-C.;Huang, C.-S.;Hsiung, C.-K.;Kao, C.-N.;Tsai, P.-C.;Liu, C.-H.;Lee, M.-H.;Dai, C.-Y.;Kao, J.-H.;Chuang, W.-L.;Lin, H.-C.;Chen, Chen C.-Y.;Tseng, K.-C.;Yu, M.-L.;investigators, on behalf of TACR |
| 國立成功大學 |
2022 |
Sofosbuvir/Velpatasvir for Hepatitis�C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, P.-N.;Mo, L.-R.;Chen, Chen C.-T.;Chen, Chen C.-Y.;Huang, C.-F.;Kuo, H.-T.;Lo, C.-C.;Tseng, K.-C.;Huang, Y.-H.;Tai, C.-M.;Peng, C.-Y.;Bair, M.-J.;Chen, Chen C.-H.;Yeh, M.-L.;Lin, C.-L.;Lin, C.-Y.;Lee, P.-L.;Chong, L.-W.;Hung, C.-H.;Chang, T.S.;Huang, J.-F.;Yang, C.-C.;Hu, J.-T.;Lin, C.-W.;Wang, C.-C.;Su, W.-W.;Hsieh, T.-Y.;Lin, C.-L.;Tsai, W.-L.;Lee, T.-H.;Chen, G.-Y.;Wang, S.-J.;Chang, Chang C.-C.;Yang, S.-S.;Wu, Wu W.-C.;Huang, C.-S.;Chou, K.-H.;Kao, C.-N.;Tsai, P.-C.;Liu, C.-H.;Lee, M.-H.;Cheng, Cheng C.-Y.;Tsai, M.-C.;Liu, C.-J.;Dai, C.-Y.;Lin, H.-C.;Kao, J.-H.;Chuang, W.-L.;Yu, M.-L.;investigators, TACR |
| 臺大學術典藏 |
2021-12-22T03:53:44Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; Tsai L.-K.; Liu Y.-B.; Huang C.-F.; Tang S.-C.; JIANN-SHING JENG |
| 臺大學術典藏 |
2021-12-22T03:53:39Z |
Factors for recurrent stroke among Asian patients with non-valvular atrial fibrillation under non-vitamin K antagonist oral anticoagulant therapy
|
Lin S.-Y.; Tang S.-C.; Tsai L.-K.; Yeh S.-J.; Huang C.-F.; JIANN-SHING JENG |
| 臺大學術典藏 |
2021-12-22T03:53:33Z |
Measurement of Dabigatran Concentration Using Finger Prick Dried Blood Spot Sample Collection
|
Lin S.-Y.; Peng Y.-F.; Huang C.-F.; Kuo C.-H.; Tang S.-C.; JIANN-SHING JENG |
| 臺大學術典藏 |
2021-12-22T03:53:31Z |
Factors Associated With Edoxaban Concentration Among Patients With Atrial Fibrillation
|
Lin S.-Y.; Kuo C.-H.; Ho L.-T.; Liu Y.-B.; Huang C.-F.; Tang S.-C.; JIANN-SHING JENG |
| 臺大學術典藏 |
2021-12-22T03:53:29Z |
Impact of different renal function equations on direct oral anticoagulant concentrations
|
Lin S.-Y.; Kuo C.-H.; Huang T.-M.; Peng Y.-F.; Huang C.-F.; Tang S.-C.; JIANN-SHING JENG |
| 臺大學術典藏 |
2021-12-02T05:41:25Z |
Primary hypogammaglobulinemia presenting with prostate abscess and Fusobacterium mortiferum bacteremia in a 28-year-old man
|
Lu C.-H.; WANG-DA LIU; Huang C.-F.; Liao C.-H.; Lan T.-Y.; Kang C.-M.; Lin C.-C.; Yang Y.-H.; Hung C.-C. |
| 臺大學術典藏 |
2021-11-26T05:56:25Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; LI-KAI TSAI; Liu Y.-B.; Huang C.-F.; Tang S.-C.; Jeng J.-S. |
| 臺大學術典藏 |
2021-11-26T05:56:20Z |
Factors for recurrent stroke among Asian patients with non-valvular atrial fibrillation under non-vitamin K antagonist oral anticoagulant therapy
|
Lin S.-Y.; Tang S.-C.; LI-KAI TSAI; Yeh S.-J.; Huang C.-F.; Jeng J.-S. |
顯示項目 91-100 / 886 (共89頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
|
